deltatrials
Active Not Recruiting PHASE4 NCT00923702

Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India

Sponsor: All India Institute of Medical Sciences

Conditions Cervical Cancer Cervical Precancerous Lesions
Interventions Prophylactic quadrivalent HPV vaccine Merck (Gardasil®)
Updated 12 times since 2017 Last updated: Sep 27, 2023 Started: Sep 30, 2009 Primary completion: Jan 31, 2017 Completion: Jul 31, 2026

Listed as NCT00923702, this PHASE4 trial focuses on Cervical Cancer and Cervical Precancerous Lesions and remains ongoing. Sponsored by All India Institute of Medical Sciences, it has been updated 12 times since 2009, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Change History

12 versions recorded

  1. Jul 2025 — Present [monthly]

    Active Not Recruiting PHASE4

  2. Feb 2025 — Jul 2025 [monthly]

    Active Not Recruiting PHASE4

  3. Nov 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE4

  4. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting PHASE4

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE4

▶ Show 7 earlier versions

  1. Oct 2023 — Jul 2024 [monthly]

    Active Not Recruiting PHASE4

  2. Nov 2022 — Oct 2023 [monthly]

    Active Not Recruiting PHASE4

    Status: Unknown Status → Active Not Recruiting

  3. Oct 2021 — Nov 2022 [monthly]

    Unknown Status PHASE4

    Status: Active Not Recruiting → Unknown Status

  4. Jan 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE4

  5. Jun 2018 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  6. Feb 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE4

  7. Jan 2017 — Feb 2017 [monthly]

    Active Not Recruiting PHASE4

    First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • All India Institute of Medical Sciences
  • Cancer Foundation of India
  • Christian Fellowship Community Health Centre
  • German Cancer Research Center
  • Gujarat Cancer & Research Institute
  • Jehangir Clinical Development Centre
  • MNJ Institute of Oncology and Regional Cancer Center
  • Nargis Datta Memorial Cancer Hospital
  • Partha Basu
  • Rajiv Gandhi Centre for Biotechnology
  • Tata Memorial Centre
Data source: International Agency for Research on Cancer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ahmedabad, India
  • • Ambilikkai, India
  • • Barshi, India
  • • Hyderabad, India
  • • Kolkata, India
  • • Mumbai, India
  • • New Delhi, India
  • • Pune, India